Is LASR a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for nLIGHT (LASR) rests on Directed-energy defense demand: The clearest driver is US government spending on high-energy laser weapons, where nLIGHT supplies lasers and beam-control systems into Army and Navy programs. The bear case rests on valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply. Analysts covering it publish targets from $55.00 to $100.00 against a $33.67 price, so even the professionals disagree by 55% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
nLIGHT, Inc. (Nasdaq: LASR) designs and manufactures high-power semiconductor and fiber lasers for three broad markets: aerospace and defense (directed-energy weapons, optical sensing), advanced manufacturing (industrial cutting, welding, additive), and microfabrication. Historically the company leaned on commercial industrial-laser sales, a competitive and cyclical business, but the growth engine has decisively shifted to defense, where nLIGHT supplies high-energy laser systems and beam-control technology to US Army and Navy programs. The company is based in Vancouver, Washington and books a large share of revenue from US government and prime-contractor programs. The investment picture is a re-rating story. Revenue reached a record ~$261 million in full-year 2025 (up ~32%), and Q1 2026 revenue jumped ~55% year over year to ~$80 million with a swing back to a small net profit and expanding gross margins, driven by record aerospace and defense product revenue. Q2 2026 then set another record, with revenue of ~$82.6 million (up ~34% year over year) and adjusted EPS of $0.15 against a $0.14 consensus, though GAAP results slipped back to a small net loss of ~$1.3 million. The stock had been rewarded aggressively for the pivot, closing at a high of $84.95 on May 11, 2026. The turn came with the August 6 report: third-quarter revenue guidance of $63-73 million left out roughly $17 million of product revenue nLIGHT had expected to ship, because parts and materials from certain Chinese suppliers were held up, and management called Q4 backlog shipments a question mark. The shares fell more than 20% the next day and kept sliding. As of October 16, 2026 LASR closed at $34.03, down ~54.8% over three months and ~11.3% year to date but still up ~7.4% over one year, for a market cap near ~$2.0 billion against ~$311 million of trailing revenue (about 6.3x sales). The defense pipeline itself has kept growing: nLIGHT holds a Joint Laser Weapon System (JLWS) agreement awarded July 9, 2026 with an initial $44 million award and a ceiling of up to $627 million. The central question is execution on the directed-energy backlog and the supply chain rather than whether the underlying business is real.
The bull case: what would have to be true for $100.00
The most optimistic published target on LASR is $100.00, +197.0% from the $33.67 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Directed-energy defense demand
The clearest driver is US government spending on high-energy laser weapons, where nLIGHT supplies lasers and beam-control systems into Army and Navy programs. Q1 2026 aerospace and defense product revenue hit a record ~$33 million (up ~98% year over year), and management pointed to a defense backlog near ~$110 million. Rising directed-energy budgets are the core bull case. The July 2026 Joint Laser Weapon System award (an Other Transaction Authority agreement with a $44 million initial award and a ceiling of up to $627 million) extends that pipeline, with sales contribution expected to start in late 2026.
2. Product scaling and new platforms
nLIGHT is pushing new high-energy laser platforms (branded families like Hades) intended to scale power and be produced at volume. As mix shifts toward these higher-value defense products and production volumes rise, gross margin has improved (to ~33% in Q1 2026 from ~27%), which is central to the profitability story. Gross margin over the trailing twelve months to June 2026 was ~31.5%, so the expansion has not yet held steady quarter to quarter.
3. Balance-sheet capacity to invest
A February 2026 equity offering left the company with roughly ~$333 million in cash and marketable securities as of Q1 2026, and cash was still about ~$330 million against ~$15 million of debt at June 30, 2026. That funding gives nLIGHT room to invest in defense manufacturing capacity and development contracts without immediate financing pressure, though the raise also diluted existing holders.
4. Optical-sensing and manufacturing exposure
Beyond weapons, nLIGHT sells lasers for optical sensing (including aerospace and space applications) and for advanced manufacturing. The commercial and industrial side is more cyclical and competitive, but it provides a second demand pool and some diversification beyond direct government programs.
5. The supply-chain bottleneck
The near-term swing factor is supply, not demand. Q3 2026 guidance of $63-73 million excluded about $17 million of product revenue held up by parts and materials from certain Chinese suppliers, and the CFO said the issue could resolve quickly or take months to quarters. Consensus for the quarter sits near ~$68 million of revenue and $0.05 of EPS ahead of the November 5, 2026 report, so how much of the delayed revenue ships, and when, is the next test.
The bear case: what would have to be true for $55.00
The most pessimistic published target is $55.00, +63.4% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks nLIGHT is worth if the risks below bite instead of the drivers above.
Valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply. Revenue is concentrated in US government and directed-energy programs, which are exposed to federal budget cycles, procurement timing, and program cancellations. The legacy commercial-laser segment faces intense competition and pricing pressure from larger players. Profitability is thin and recent, so a return to losses is possible if mix or volumes weaken, and the February 2026 equity raise diluted shareholders. Lumpy defense revenue recognition can also make quarterly results volatile. Supply-chain dependence is now a demonstrated risk: reliance on certain Chinese suppliers for parts and materials pushed about $17 million of expected product revenue out of the third-quarter 2026 outlook, and the shares fell ~55% over the following three months. Insider selling during the decline, including a CEO sale of 215,000 shares for about $8.9 million reported in September 2026, has added to the pressure on sentiment.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding LASR already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on LASR
8 analysts cover LASR, with an average target of $82.12 (+143.9% against $33.67) and a split of 9 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the LASR forecast and price target page.
How is LASR valued? (as of October 2026)
Snapshot for LASR as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$311M
- Revenue growth (Q2 2026, YoY): ~34%
- Q3 2026 revenue guidance: $63-73M (supply-constrained)
- Gross margin (TTM): ~31.5%
- Net income (TTM): ~-$12.5M
- Price-to-sales: ~6.3x
- Cash & securities: ~$330M (debt ~$15M)
- Market cap: ~$2.0B
As of October 16, 2026, nLIGHT's market cap of roughly ~$2.0 billion is about 6.3x its ~$311 million of trailing revenue, down from roughly 15x in May before supply-chain problems clouded the second half of 2026. The company is near breakeven on a GAAP basis (a trailing net loss of about $12.5 million) and holds about $330 million of cash with little debt, so the premium still rests on directed-energy growth, including the JLWS award, rather than current earnings. Third-quarter results are due November 5, 2026.
How do you decide if LASR is a buy?
Rather than asking whether LASR is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold LASR indirectly through an index or sector ETF before adding more.
What would change your mind on LASR
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Directed-energy defense demand stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the LASR stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about LASR against your real portfolio and see your actual exposure before deciding.
Investing in nLIGHT with AI
Connect the broker you already use and ask Walnut's AI how LASR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is LASR a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Directed-energy defense demand, with revenue (ttm) at ~$311M. The bear case rests on valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply. Analysts covering it are spread from $55.00 to $100.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell LASR?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $55.00, +63.4% from the $33.67 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for LASR?
+
Directed-energy defense demand. The clearest driver is US government spending on high-energy laser weapons, where nLIGHT supplies lasers and beam-control systems into Army and Navy programs. The most optimistic analyst target on LASR is $100.00, +197.0% from the $33.67 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for LASR?
+
Valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply. Revenue is concentrated in US government and directed-energy programs, which are exposed to federal budget cycles, procurement timing, and program cancellations. The legacy commercial-laser segment faces intense competition and pricing pressure from larger players. Profitability is thin and recent, so a return to losses is possible if mix or volumes weaken, and the February 2026 equity raise diluted shareholders. Lumpy defense revenue recognition can also make quarterly results volatile. Supply-chain dependence is now a demonstrated risk: reliance on certain Chinese suppliers for parts and materials pushed about $17 million of expected product revenue out of the third-quarter 2026 outlook, and the shares fell ~55% over the following three months. Insider selling during the decline, including a CEO sale of 215,000 shares for about $8.9 million reported in September 2026, has added to the pressure on sentiment. The most pessimistic published target is $55.00, +63.4% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does nLIGHT do?
+
nLIGHT, Inc. engages in the design, development, manufacture, and sale of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications.
What would have to change for LASR to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Directed-energy defense demand) stalling in the reported numbers rather than in the narrative, the risk above (valuation is the dominant risk: even after the autumn 2026 sell-off the stock trades at roughly 6.3x trailing sales and a high forward earnings multiple, the stock is priced for sustained rapid growth, so any deceleration in defense orders could compress the multiple sharply) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does nLIGHT (LASR) actually do?
+
nLIGHT designs and builds high-power semiconductor and fiber lasers. Its products go into directed-energy weapons and optical sensing for aerospace and defense, plus industrial cutting, welding, and microfabrication for commercial manufacturing.
Why has LASR stock moved so much?
+
The company pivoted toward aerospace and defense, where revenue is growing fast on US directed-energy programs. Q1 2026 revenue rose ~55% year over year with record defense product sales, and investors re-rated the stock as a defense-laser growth name. Then it reversed: after August 2026 guidance showed about $17 million of expected revenue held up by Chinese supplier problems, the shares fell more than 20% in a day and ended down ~55% over three months to $34.03 on October 16, 2026.
Is nLIGHT profitable?
+
It posted a full-year 2025 net loss of about $23.5 million, swung to a small net profit in Q1 2026 as gross margin expanded to ~33% on higher defense volumes, then slipped back to a net loss of about $1.3 million in Q2 2026. Trailing net income was about -$12.5 million at mid-2026, so profitability is still thin and can swing with mix, volumes, and supply.
Walnut is informational, not investment advice, and gives no verdict on LASR. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.